College Clinical Advisers Denise Voon MCOptom, Dr Paramdeep Bilkhu MCOptom, and Daniel Hardiman-McCartney FCOptom MBE discuss the recent news from the Medicines and Healthcare products Regulatory Agency (MHRA) approving the first low-dose atropine treatment for myopia in the UK. 

They talk about what the news means for optometrists and answer questions from College members. 

Further information

• Myopia management
• Guidance for assessing and managing children with myopia
• MHRA approves first licensed low-dose atropine treatment for childhood myopia in the UK

• Expanding Prescribing Scope of Practice - Royal Pharmaceutical Society